Recent Medical releases

[PRESSWIRE] Hungary – 09 May, 2019 -- People go from all parts of the world to Budapest (Hungary, Europe) to get their teeth fixed and save up to 70% on dental care. It is no matter if it is about a complete smile makeover or just some lost teeth should be replaced by implants or a couple of crowns should be fitted, one of the most preferred destinations is Budapest.

 [PRESSWIRE] LAGUNA HILLS, Calif. - May 1, 2019 -- Prelude Corporation (PreludeDx), a leader in molecular diagnostics and personalized medicine for early stage breast cancer, will present interim results from its large PREDICT study during a poster presentation (Abstract ID: 581643), titled "Interim Analysis of the DCISionRT PREDICT Study: Clinical Utility of a Biologic Signature Predictive of Radiation Therapy (RT) Benefit in Patients with DCIS", at the American Society of Breast Surgeons (ASBrS) Annual Meeting in Dallas, TX.

[PRESSWIRE] Parma - April 26, 2019 -- The recently published CREDENCE study [1] showed that SGLT2 inhibitors can slow progression of chronic kidney disease (CKD) in diabetes patients in addition to the effects seen with RAAS blockade. The study results were presented at the World Nephrology Congress in Melbourne and showed that Canagliflozin was associated with a 34% risk reduction of the renal end point (end stage renal disease, doubling of serum creatinine or renal death). The previous day, the SONAR study had shown that the selective endothelin A receptor antagonist, atrasentan, reduced the risk of renal events in a specially selected CKD cohort with diabetes to a similar extent (35%).

[PRESSWIRE] Parma – 18 April 2019 -- Kidney transplantation is the best renal replacement therapy available. Although survival and quality of life are significantly better compared to dialysis patients, transplant recipients nevertheless have a significantly higher cardiovascular morbidity and mortality than healthy people. One recently published study [1] shows current data and derives important conclusions for further long-term improvements in outcomes after kidney transplantation – a highly topical issue, especially for cost reasons and in the event of organ or donor scarcity.

[PRESSWIRE] Parma – 10 April, 2019 -- Chronic kidney disease (CKD) is increasingly recognized as a systemic condition. It also impacts upon other organ systems and in recent years much attention has focussed specifically on the link between the kidneys and the heart. There is also an association between brain dysfunction and kidney disease; new data shows that even mild CKD correlates with impairment of cognitive function. A new review by Professor Giovambattista Capasso summarizes the current evidence in this field.

 [PRESSWIRE] CHICAGO, April 9, 2019 -- Citizens United for Research in Epilepsy (CURE) announced today the appointment of Beth Lewin Dean, MBA, MPA as the new Chief Executive Officer. Beth brings 17 years of extensive experience within the epilepsy field, which has been driven by her strong commitment to understanding the needs, aspirations and hopes of patients and their loved ones.  

 [PRESSWIRE] YORBA LINDA, Calif., April 9, 2019 -- Breaking from the traditional format of Liveyon's live 'Pure-Cast,' Liveyon founder and CEO sat down with his mother, Lois Christianson, in a heartfelt conversation on how stem cell treatment saved her life after a horrifying injury.

 [PRESSWIRE] MOUNTAIN VIEW, Calif., April 1, 2019 -- GetInsured, a leading provider of health insurance marketplace platforms, has abolished $1,856,771.28 of residents' medical debt in its home state of California, to help alleviate some of the severe financial hardship caused by unpaid and un-payable medical bills.

 [PRESSWIRE] PEORIA, Ill., March 27, 2019 -- A new collaboration between Peoria, Illinois-based OSF HealthCare and Redox, based in Madison, Wisconsin, will allow the health system to effectively integrate pilot programs and deploy digital health solutions to improve health for OSF HealthCare communities. Redox will serve as an application layer connecting third-party technology solutions to the OSF HealthCare clinical systems.

 [PRESSWIRE] SAN DIEGO, March 27, 2019 -- Tocagen Inc. (Nasdaq: TOCA), a clinical-stage, cancer-selective gene therapy company, today announced three presentations of updated clinical and preclinical data at the American Association for Cancer Research (AACR) Annual Meeting 2019, to be held March 29-April 3 in Atlanta and the 2019 American Association of Neurological Surgeons (AANS) Annual Meeting, to be held April 13-17 in San Diego.